Clinical Trials
60 trialsNOECHO
Skribe Medical
Semmelweis Esophageal Cancer Study: Noninvasive Prognostic Parameters in Patients With Oesophageal and Esophagogastric Junction Cancer
Semmelweis University
Risk Stratification of Cancer Therapy-Related Cardiac Dysfunction Using AI-Enhanced Electrocardiography
Yonsei University
ML-CardioTox
University Hospital, Caen
CardioNETPOL
National Institute of Cardiology, Warsaw, Poland
SCPC
University Hospital Muenster
TRPC6 Characterization to Predict and Prevent Chemotherapy Related Cardiomyopathy and Heart Failure With Breast Cancer
Mayo Clinic
BREACH-fMRI
University Hospital, Geneva
Symptom Burden and Health Related Quality of Life of Cancer Patients With Concurrent Heart Failure
M.D. Anderson Cancer Center
PAtient Similarity for Decision-Making in Prevention of Cardiovascular Toxicity (PACT): A Feasibility Study
Medical College of Wisconsin
CLARITY
The Netherlands Cancer Institute
Patient Reported Unmet Needs for Function and Supportive Occupational- and Physiotherapy Rehabilitation Interventions
Rigshospitalet, Denmark
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
EMPOWER
Future Genetics Limited
Cardiovascular Multimodality Imaging Study
Montefiore Medical Center
Identification of Anticancer Drugs Associated With Cancer Therapy-related Cardiac Dysfunction: a Pharmacovigilance Study
University Hospital, Caen
CATCH-HF
University of California, San Diego
Comparing the Diagnostic Sensitivity and Specificity of Pleural Fluid N-Terminal Pro B-type Natriuretic Peptide (NT-proBNP) and Other Biochemical Gradient Criteria in Distinguishing Heart Failure and Non-heart Failure Related Pleural Effusions (CENTRE Study)
Chinese University of Hong Kong
QUANTUM
VitaMed Research LLC
Emulation of the Moderate Alcohol and Cardiovascular Health Trial (MACH15)
Harvard School of Public Health (HSPH)
Multi-mobility
Northumbria University
BLOC-II
University Medical Center Groningen
FATIGUE
University of Aberdeen
PatientSpot Formerly Known as ArthritisPower
Global Healthy Living Foundation
LTC
King's College London
PTN_POPS
Duke University
UCARE
National University of Ireland, Galway, Ireland
CASPER
Istanbul University
CARES
TidalSense
NEOCARDIO
Groupe Hospitalier Pitie-Salpetriere
iCare
Charite University, Berlin, Germany
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
A Study of Special Use Results Surveillance of Revlimid 5mg Capsules
Celgene
A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myeloma Who Have Received Long-term Treatment With it Under the Actual Condition of Use
Celgene
Identification of Novel Inflammation-related Biomarkers for Early Detection of Anthracycline-induced Cardiotoxicity in Breast Cancer Patients
University Hospital, Essen
Evaluation and Management of Cardio Toxicity in Oncologic Patients
Tel-Aviv Sourasky Medical Center
SELF - BREATHE for Chronic Breathlessness
King's College Hospital NHS Trust
The Role of suPAR Biomarker in Blood Samples of Breast Cancer Patients During and Post Doxorubicin Chemotherapy: Causative vs. Predictor
Rush University Medical Center
Personalized Experiences to Inform Improved Communication for Minorities With Life Limiting Illness
University of Colorado, Denver
ACCEPT
Clinical Evaluation Research Unit at Kingston General Hospital
PROTECT
Vanderbilt University Medical Center
ICARE
European Georges Pompidou Hospital
Early Detection of Heart Problems in Cancer Patients Receiving Chemotherapy
The Guthrie Clinic
COMO-GMC
University of Aarhus
Cardiomyopathy Tissue Bank in a Cancer Population
M.D. Anderson Cancer Center
Novel Biomarkers and Echocardiography for Subclinical Cardiac Toxicity in Breast Cancer Patients Receiving Anthracyclines
Stony Brook University
CaTOB
Odense University Hospital
Strain Imaging in Breast Cancer Patients Receiving Trastuzumab
University of Florida
Early Detection of Cardiac Toxicity in Childhood Cancer Survivors
Children's National Research Institute
ARBITRAGE
Groupe Hospitalier Pitie-Salpetriere